rs34241435

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The ENST00000928026.1(SCNN1B):​c.-76G>A variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.126 in 152,150 control chromosomes in the GnomAD database, including 2,946 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.13 ( 2946 hom., cov: 31)

Consequence

SCNN1B
ENST00000928026.1 5_prime_UTR

Scores

3

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -0.207

Publications

3 publications found
Variant links:
Genes affected
SCNN1B (HGNC:10600): (sodium channel epithelial 1 subunit beta) Nonvoltage-gated, amiloride-sensitive, sodium channels control fluid and electrolyte transport across epithelia in many organs. These channels are heteromeric complexes consisting of 3 subunits: alpha, beta, and gamma. This gene encodes the beta subunit, and mutations in this gene have been associated with pseudohypoaldosteronism type 1 (PHA1), and Liddle syndrome. [provided by RefSeq, Apr 2009]
SCNN1B Gene-Disease associations (from GenCC):
  • Liddle syndrome 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, PanelApp Australia, Labcorp Genetics (formerly Invitae)
  • pseudohypoaldosteronism, type IB2, autosomal recessive
    Inheritance: AR Classification: DEFINITIVE Submitted by: Ambry Genetics
  • pseudohypoaldosteronism, type IB1, autosomal recessive
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, Orphanet
  • Liddle syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • bronchiectasis with or without elevated sweat chloride 1
    Inheritance: SD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript ENST00000928026.1, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.97).
BP6
Variant 16-23301864-G-A is Benign according to our data. Variant chr16-23301864-G-A is described in ClinVar as Benign. ClinVar VariationId is 1233203.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.364 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000928026.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt

There are no transcript annotations for this variant.

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SCNN1B
ENST00000928026.1
c.-76G>A
5_prime_UTR
Exon 1 of 13ENSP00000598085.1
SCNN1B
ENST00000928027.1
c.-111G>A
5_prime_UTR
Exon 1 of 13ENSP00000598086.1
SCNN1B
ENST00000928028.1
c.-76G>A
5_prime_UTR
Exon 1 of 13ENSP00000598087.1

Frequencies

GnomAD3 genomes
AF:
0.125
AC:
19044
AN:
152032
Hom.:
2929
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.369
Gnomad AMI
AF:
0.0241
Gnomad AMR
AF:
0.0452
Gnomad ASJ
AF:
0.0173
Gnomad EAS
AF:
0.000385
Gnomad SAS
AF:
0.00788
Gnomad FIN
AF:
0.0309
Gnomad MID
AF:
0.0316
Gnomad NFE
AF:
0.0364
Gnomad OTH
AF:
0.0824
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.126
AC:
19098
AN:
152150
Hom.:
2946
Cov.:
31
AF XY:
0.122
AC XY:
9052
AN XY:
74384
show subpopulations
African (AFR)
AF:
0.369
AC:
15297
AN:
41448
American (AMR)
AF:
0.0451
AC:
689
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.0173
AC:
60
AN:
3470
East Asian (EAS)
AF:
0.000386
AC:
2
AN:
5178
South Asian (SAS)
AF:
0.00810
AC:
39
AN:
4816
European-Finnish (FIN)
AF:
0.0309
AC:
328
AN:
10614
Middle Eastern (MID)
AF:
0.0340
AC:
10
AN:
294
European-Non Finnish (NFE)
AF:
0.0364
AC:
2477
AN:
68014
Other (OTH)
AF:
0.0825
AC:
174
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
667
1334
2001
2668
3335
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
168
336
504
672
840
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0799
Hom.:
2497
Bravo
AF:
0.137
Asia WGS
AF:
0.0330
AC:
115
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.97
CADD
Benign
2.3
DANN
Benign
0.78
PhyloP100
-0.21
PromoterAI
0.013
Neutral

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs34241435;
hg19: chr16-23313185;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.